Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mallory L Hacker

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 20, 2020
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseD Luke Fischer, Peggy Auinger, John L Goudreau, et al.
Neuromodulation : Journal of the International Neuromodulation Society|July 21, 2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseCaryl E Sortwell, Mallory L Hacker, David Luke Fischer, et al.
Neurology|July 1, 2020
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomesMallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, et al.
Journal of Parkinson'S Disease|March 12, 2016
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's DiseaseMallory L Hacker, Amanda D Currie, Anna L Molinari, et al.
Clinical Rehabilitation|October 12, 2020
A comparative evaluation of telehealth and direct assessment when screening for spasticity in residents of two long-term care facilitiesKelly A Harper, Emily C Butler, Mallory L Hacker, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
Neurology|July 1, 2018
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson diseaseMallory L Hacker, Mahlon R DeLong, Maxim Turchan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 20, 2020
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseD Luke Fischer, Peggy Auinger, John L Goudreau, et al.
Neuromodulation : Journal of the International Neuromodulation Society|July 21, 2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseCaryl E Sortwell, Mallory L Hacker, David Luke Fischer, et al.
Neurology|July 1, 2020
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomesMallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, et al.
Journal of Parkinson'S Disease|March 12, 2016
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's DiseaseMallory L Hacker, Amanda D Currie, Anna L Molinari, et al.
Clinical Rehabilitation|October 12, 2020
A comparative evaluation of telehealth and direct assessment when screening for spasticity in residents of two long-term care facilitiesKelly A Harper, Emily C Butler, Mallory L Hacker, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
Neurology|July 1, 2018
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson diseaseMallory L Hacker, Mahlon R DeLong, Maxim Turchan, et al.
Pageof 3